<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: Re: *sox18* in the bag</TITLE>
<META NAME="Author" CONTENT="Damien Broderick (d.broderick@english.unimelb.edu.au)">
<META NAME="Subject" CONTENT="Re: *sox18* in the bag">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>Re: *sox18* in the bag</H1>
<!-- received="Tue Mar 28 23:12:10 2000" -->
<!-- isoreceived="20000329061210" -->
<!-- sent="Wed, 29 Mar 2000 16:16:31 +1000" -->
<!-- isosent="20000329061631" -->
<!-- name="Damien Broderick" -->
<!-- email="d.broderick@english.unimelb.edu.au" -->
<!-- subject="Re: *sox18* in the bag" -->
<!-- id="3.0.1.32.20000329161631.00786150@ariel.its.unimelb.edu.au" -->
<!-- inreplyto="200003281700.JAA22387@finney.org" -->
<STRONG>From:</STRONG> Damien Broderick (<A HREF="mailto:d.broderick@english.unimelb.edu.au?Subject=Re:%20*sox18*%20in%20the%20bag&In-Reply-To=&lt;3.0.1.32.20000329161631.00786150@ariel.its.unimelb.edu.au&gt;"><EM>d.broderick@english.unimelb.edu.au</EM></A>)<BR>
<STRONG>Date:</STRONG> Tue Mar 28 2000 - 23:16:31 MST
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="6042.html">Rob Sweeney: "Re: Transhuman fascists?"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="6040.html">Til Eulenspiegel: "Status of Locator Service?"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="6012.html">hal@finney.org: "Re: *sox18* in the bag"</A>
<!-- nextthread="start" -->
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#6041">[ date ]</A>
<A HREF="index.html#6041">[ thread ]</A>
<A HREF="subject.html#6041">[ subject ]</A>
<A HREF="author.html#6041">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
At 09:00 AM 28/03/00 -0800, Hal wrote:
<BR>
<P><EM>&gt;Just knowing a gene's sequence does not automatically give you the ability
</EM><BR>
<EM>&gt;to control its activities.
</EM><BR>
<P>The researchers, I now find, are Drs Peter Koopman and George Muscat, of
<BR>
the Institute for Molecular Bioscience, University of Queensland. Their
<BR>
paper on *Sox18* is in this week's *Nature Genetics* (which I haven't yet
<BR>
seen). What they've done is pinpoint *Sox18* as a/the main player in the
<BR>
vascularisation transcription flowchart in `ragged mice'. 
<BR>
<P>Koopman's page sez, inter alia:
<BR>
<P>Molecular genetic control of vascular development
<BR>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have recently isolated and characterised a
<BR>
novel gene called
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sox18. In situ hybridization experiments in mouse
<BR>
embryos has
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;revealed a striking correlation between sites of
<BR>
Sox18 expression and
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the formation of endothelial cells of the
<BR>
developing vasculature
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;throughout the embryo (see Figure). We have found
<BR>
that Sox18
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;expression is lacking in embryos deficient in
<BR>
Flk1, confirming a role
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for Sox18 in the VEGF-Flk1 pathway of endothelial
<BR>
cell
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;differentiation and mitogenesis. In addition we
<BR>
have shown that
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sox18 mutations underlie the mouse mutant Ragged
<BR>
(Ra), which is
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;characterized by an edematous phenotype
<BR>
suggesting blood vessel
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dysfunction.
<BR>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The aim of this project is to clarify the role of
<BR>
Sox18 in the
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;development and function of the vascular system. We are thoroughly
<BR>
investigating the
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;expression of Sox18 during blood vessel development in embryos,
<BR>
adults and tumours, and
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;are inactivating Sox18 by homologous recombination.
<BR>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The overall hypothesis being tested is that Sox18 is an important
<BR>
component of the
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;molecular pathway of blood vessel development, and as such may be an
<BR>
entry point to
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;novel therapeutic strategies for vascular diseases, or other
<BR>
diseases in which blood vessels
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;play an important part, such as cancer. This work may in the longer
<BR>
term suggest new
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;avenues of therapeutic intervention that may be applicable to
<BR>
suppression of tumour
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;growth and metastasis.
<BR>
<P>Damien
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="6042.html">Rob Sweeney: "Re: Transhuman fascists?"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="6040.html">Til Eulenspiegel: "Status of Locator Service?"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="6012.html">hal@finney.org: "Re: *sox18* in the bag"</A>
<!-- nextthread="start" -->
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#6041">[ date ]</A>
<A HREF="index.html#6041">[ thread ]</A>
<A HREF="subject.html#6041">[ subject ]</A>
<A HREF="author.html#6041">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Thu Jul 27 2000 - 14:06:41 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
